A cohort study for patients with Gestational Trophoblastic Neoplasia
Clinical Specialty Queue For Gestational Trophoblastic Neoplasia
This study is gathering information from patients with Gestational Trophoblastic Neoplasia to better understand their treatment and outcomes, including fertility and recurrence rates.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Women's Hospital School Of Medicine Zhejiang University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Zhengjiang, Hangzhou) |
| Trial ID | NCT06681259 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive cohort of patients diagnosed with Gestational Trophoblastic Neoplasia (GTN) by collecting data from both retrospective and prospective cases across multiple tertiary hospitals. It will establish standardized criteria for patient inclusion and exclusion, gather baseline information such as age, reproductive history, and genetic data, and collect biological specimens. Additionally, the study will monitor patients' treatment plans, hCG levels, side effects, and follow-up outcomes including fertility status and recurrence rates.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been clinically diagnosed with GTN.
Not a fit: Patients with mental illness, cognitive impairment, or concurrent malignant tumors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of GTN, leading to improved patient outcomes.
How similar studies have performed: While there have been studies on GTN, this specific cohort approach is relatively novel and aims to unify data collection across multiple centers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ① Age ≥ 18 years old; ② Patients clinically diagnosed with GTN (including invasive cases) Molar pregnancy, choriocarcinoma, PSTT, ETT); ③ Complete informed consent for enrollment. Exclusion Criteria: * ① Having mental illness or cognitive impairment, unable to cooperate in completing the investigation with Patients with concurrent malignant tumors; ③ Participants with severe missing follow-up data.
Where this trial is running
Zhengjiang, Hangzhou
- Weiguo Lv — Zhengjiang, Hangzhou, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.